Capsule-sponge DNA methylation test boosts Barrett’s screening access, showing high accuracy, strong tolerability, and promise for primary care triage to endoscopy.
|Articles|August 14, 2013
In Cholelithiasis, What Role for Ursodeoxycholic Acid Rx?
In patients in whom cholelithiasis with numerous stones is incidentally noted on imaging, should ursodeoxycholic acid be considered to help dissolve the stones and reduce the risk of biliary disease?
Advertisement
In patients in whom cholelithiasis with numerous stones is incidentally noted on imaging, ursodeoxycholic acid (ursodiol) should be considered to help dissolve the stones and reduce the risk of biliary disease.
a. True
b. False
Advertisement
Related to this article
Post hoc LUCENT-2 and VIVID-1 analyses show more mirikizumab-treated patients reached steroid-free composite remission in UC and Crohn disease at 1 year.
New research underscores the need for public health interventions to improve the microbial and fiber content of diets in the US.
Advertisement
Advertisement
Trending on Patient Care Online
1
Menopause Hormone Therapy Linked to Greater Weight Loss With Semaglutide in Real-World Study
2
Capsule-Sponge Testing Could Help Close the Barrett’s Screening Gap: An Expert Q&A
3
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
4
Menopause Diagnoses Documented in Just 7.8% of Midlife Women's Outpatient Visits, Study Finds
5